专利检索 ap:("VIROGENETICS CORPORATION" OR "The Government of the United States of America as represented by the Secretary, Department of Health AND Human Services") AND inv:"FRANCHINI, Genoveffa" 第 1 页

1.

发明授权
IMMUNODEFICIENCY VIRUS RECOMBINANT POXVIRUS VACCINE 失效
标题翻译：重组HIV特异性疫苗POXVIRU

公开(公告)号：EP0592546B1

公开(公告)日：2003-05-28

申请号：EP92914713.0

申请日：1992-06-12

申请人： VIROGENETICS CORPORATION , The Government of the United States of America as represented by the Secretary, Department of Health and Human Services

发明人： PAOLETTI, Enzo , TARTAGLIA, James , COX, William, I. , GALLO, Robert , FRANCHINI, Genoveffa

IPC分类号： C12N7/00 , A61K39/12 , C12N15/86 , C12N15/49

CPC分类号： C12N15/86 , A61K39/00 , A61K2039/5254 , C07K14/005 , C07K14/33 , C12N2710/24043 , C12N2710/24143 , C12N2740/15022 , C12N2740/16122 , C12N2740/16222

2.

发明公开
NOVEL CHIMERIC REV, TAT, AND NEF ANTIGENS 审中-公开
标题翻译：新的嵌合REV，TAT和Nef抗原

公开(公告)号：EP1456376A2

公开(公告)日：2004-09-15

申请号：EP02805519.2

申请日：2002-11-15

申请人： THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES , Aventis Pasteur

发明人： FRANCHINI, Genoveffa , HEL, Zdenek , TARTAGLIA, James

IPC分类号： C12N15/00

CPC分类号： C07K14/005 , A61K39/12 , A61K39/21 , A61K2039/53 , A61K2039/545 , C07K2319/00 , C07K2319/40 , C07K2319/42 , C12N2710/24043 , C12N2740/15022 , C12N2740/15034 , C12N2740/16322 , C12N2740/16334

摘要： This invention provides novel HIV antigens comprising chimeric rev, tat, and nef for use in inducing an immune response. The novel antigens can be used as vaccines to prevent and/or attenuate HIV infection.

3.

发明公开
IMMUNOGENIC COMPOSITIONS CONTAINING RECOMBINANT ATTENUATED POXVIRUSES EXPRESSING HTLV ANTIGENS 失效
标题翻译：免疫原性组合物WHAT重组减毒痘病毒包含抗原HTLV EXPREMIEREN

公开(公告)号：EP0805854A1

公开(公告)日：1997-11-12

申请号：EP96902688.0

申请日：1996-01-16

申请人： VIROGENETICS CORPORATION

发明人： PAOLETTI, Enzo , TARTAGLIA, James , FRANCHINI, Genoveffa , GALLO, Robert, C.

IPC分类号： C12N15 , A61K39 , A61P31 , C07K14 , C07K16 , C12N7 , C12P21

CPC分类号： C12N7/00 , A61K39/00 , A61K39/12 , A61K39/205 , A61K39/21 , A61K2039/5256 , A61K2039/54 , A61K2039/545 , C07K14/005 , C12N15/86 , C12N2710/24043 , C12N2710/24143 , C12N2740/14022 , C12N2740/14034 , C12N2760/20122 , C12N2760/20134

摘要： Attenuated recombinant viruses containing DNA encoding an HTLV antigen such as HTLVenv or HTLV1171, as well as methods and compositions employing the viruses, expression products therefrom, and antibodies generated from the viruses or expression products, are disclosed and claimed. The recombinant viruses can be NYVAC or ALVAC recombinant viruses. The recombinant viruses and gene products therefrom and antibodies generated by the viruses and gene products have several preventive, therapeutic and diagnostic uses.